Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
6 studies found for:    "Albrights hereditary osteodystrophy"
Show Display Options
Rank Status Study
1 Recruiting Albright Hereditary Osteodystrophy: Growth Hormone Trial and Cognitive/Behavioral Assessments
Conditions: Pseudohypoparathyroidism Type 1a;   Albright Hereditary Osteodystrophy
Interventions: Drug: Growth hormone;   Drug: Growth Hormone
2 Completed Theophylline as a Treatment for Children With Pseudohypoparathyroidism Type 1a (Albright Hereditary Osteodystrophy)
Conditions: Pseudohypoparathyroidism Type 1a;   Albright Hereditary Osteodystrophy
Intervention: Drug: Theophylline
3 Active, not recruiting Energy Expenditure and Body Composition in Pseudohypoparathyroidism 1a
Conditions: Pseudohypoparathyroidism Type 1A;   Albright Hereditary Osteodystrophy
Intervention:
4 Recruiting Early-onset Obesity and Cognitive Impairment in Children With Pseudohypoparathyroidism
Conditions: Pseudohypoparathyroidism;   Albright Hereditary Osteodystrophy
Intervention:
5 Unknown  Evaluation of rhGH Replacement Therapy in Patients With Pseudohypoparathyroidism Type Ia (PHP Ia)
Conditions: Pseudohypoparathyroidism;   Growth Hormone Deficiency, Dwarfism
Intervention: Drug: recombinant human somatotropin
6 Recruiting Resistance to Vitamin D or Parathyroid Hormone
Conditions: Hypocalcemia;   Pseudohypoparathyroidism;   Albright Hereditary Osteodystrophy;   Rickets
Intervention:

Study has passed its completion date and status has not been verified in more than two years.